http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-104577-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1782fde68e8711188a1881f5284fe0b0 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-453 |
| filingDate | 2016-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-104577-A2 |
| titleOfInvention | METHODS TO TREAT OR REDUCE THE LIKELIHOOD OF ACQUIRING SYMPTOMS OR DISEASES DUE TO MENOPAUSE |
| abstract | Claim 1: A method for treating and / or reducing the probability of acquiring symptoms or diseases due to menopause, in postmenopausal women, characterized in that said method comprises administering a sexual steroid precursor selected from the group consisting of dehydroepiandrosterone, dehydroepiandrosterone sulfate, androst-5-en-3b, 17b-diol and 4-androsten-3.17-dione a patient in need of such treatment, wherein said sex steroid precursor is administered as a therapeutic amount that increases the metabolite level of androgen in the circulation without increasing the level of estradiol in circulation above the values observed in normal postmenopausal women in order to avoid the risk of breast and uterine cancer. Claim 2: The method of claim 1, characterized in that the sex steroid precursor is administered on the skin. Claim 3: The method of claim 1, characterized in that the sex steroid precursor is administered intravaginally. Claim 4: The method of claim 1, characterized in that the sex steroid precursor is administered orally. Claim 24: The method of claims 21 and 22, characterized in that the selective estrogen receptor modulator has the chemical structure of formula (1). |
| priorityDate | 2007-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.